PTTG1 and colorectal carcinoma: We investigated whether deregulation of the β-catenin/TCF-signalling pathway leading to the accumulation of β-catenin in colorectal carcinoma causes high expression of securin in these tumours, which may contribute to tumour progression and poor prognosis.